ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
3,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
4,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
5,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
5,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
7,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
7,2,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
7,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9,1,Daydreaming,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
9,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
9,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
9,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
10,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10,2,Labelled drug-food interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
11,2,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
12,1,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
13,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
13,3,Platelet aggregation abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
14,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
14,2,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
15,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
15,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
15,3,Hypermethioninaemia,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
15,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
15,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
15,6,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
15,7,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
16,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
16,2,Hypermethioninaemia,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
16,3,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
17,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
17,2,Hypermethioninaemia,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
17,3,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
17,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
17,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
17,6,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
18,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
18,2,Hypermethioninaemia,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
18,3,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
19,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
19,2,Hypermethioninaemia,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
19,3,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
19,4,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
19,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
20,2,Hypermethioninaemia,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
20,3,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
20,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
21,2,Hypermethioninaemia,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
21,3,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
21,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
21,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
23,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
23,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
23,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
23,4,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
23,5,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
23,6,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
23,7,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
23,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
24,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
24,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
24,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
25,2,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
25,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
26,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
26,2,Nasal irrigation,Nasal therapeutic procedures,Head and neck therapeutic procedures,Surg,N
26,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
26,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
27,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
27,2,Hypermethioninaemia,Inborn errors of amino acid metabolism,Metabolic and nutritional disorders congenital,Cong,N
27,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
28,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
